Presentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre

dc.contributor.authorKum, F.
dc.contributor.authorBeckmann, K.
dc.contributor.authorAya, H.
dc.contributor.authorSingh, S.
dc.contributor.authorSandhu, P.
dc.contributor.authorSra, S.
dc.contributor.authorRusere, J.
dc.contributor.authorZisengwe, G.
dc.contributor.authorSantaolalla, A.
dc.contributor.authorCathcart, P.
dc.contributor.authorChallacombe, B.
dc.contributor.authorBrown, C.
dc.contributor.authorPopert, R.
dc.contributor.authorDasgupta, P.
dc.contributor.authorVan Hemelrijck, M.
dc.contributor.authorElhage, O.
dc.date.issued2021
dc.description.abstract<h4>Background</h4>Experiences of African/Afro-Caribbean men on active surveillance (AS) for prostate cancer (PCa) in the United Kingdom (UK) are not well documented. We compared follow-up appointments, adherence, and clinical outcomes among African/Afro-Caribbean men on AS at a high-volume UK hospital with other ethnicities.<h4>Methods</h4>Men with confirmed low-intermediate risk Pca who attended the AS clinic (2005-2016) and had undergone ≥1 follow-up biopsy (n = 458) were included. Non-adherence (defined as >20% missed appointments), suspicion of disease progression (any upgrading, >30% positive cores, cT-stage > 3, PIRADS > 3), any upgrading from diagnostic biopsy and conversion to active treatment (prostatectomy, radiotherapy or hormone therapy) according to ethnicity (African/Afro-Caribbean versus other ethnicities) were assessed using multivariable regression analysis.<h4>Results</h4>Twenty-three percent of eligible men were recorded as African/Afro-Caribbean, while the remainder were predominantly Caucasian. African/Afro-Caribbean men had slightly lower PSA at diagnosis (median 5.0 vs. 6.0 ng/mL) and more positive cores at diagnosis (median 2 vs. 1). They had a substantially higher rate of non-attendance at scheduled follow-up visits (24% vs. 10%, p < 0.001). Adjusted analyses suggest African/Afro-Caribbean men may be at increased risk of disease progression (hazard ratio [HR]: 1.38; 95% confidence interval [CI] 0.99-1.91, P = 0.054) and upgrading (HR: 1.29; 95% CI 0.87-1.92, P = 0.305), though neither reached statistical significance. No difference in risk of conversion to treatment was observed between ethnic groups (HR: 1.03; 95% CI 0.64-1.47, P = 0.873).<h4>Conclusions</h4>African/Afro-Caribbean men on AS for PCa in the UK are less likely to adhere to scheduled appointments, suggesting a more tailored service addressing their specific needs may be required. While African/Afro-Caribbean men were no more likely to convert to treatment than Caucasian/other men, findings of a potentially higher risk of disease progression signal the need for careful selection and monitoring of African/Afro-Caribbean men on AS. Larger prospective, multicentre studies with longer follow-up are required to provide more definitive conclusions.
dc.identifier.citationProstate Cancer and Prostatic Diseases, 2021; 24(2):549-557
dc.identifier.doi10.1038/s41391-020-00313-0
dc.identifier.issn1365-7852
dc.identifier.issn1476-5608
dc.identifier.orcidBeckmann, K. [0000-0002-9798-1479]
dc.identifier.urihttps://hdl.handle.net/11541.2/147032
dc.language.isoen
dc.publisherSPRINGERNATURE
dc.relation.fundingNHMRC 1124210
dc.relation.granthttp://purl.org/au-research/grants/nhmrc/GNT1124210
dc.rightsCopyright 2021 The Author(s), under exclusive licence to Springer Nature Limited part of Springer Nature.
dc.source.urihttps://doi.org/10.1038/s41391-020-00313-0
dc.subjectHumans
dc.subjectProstatic Neoplasms
dc.subjectPrognosis
dc.subjectProstatectomy
dc.subjectSurvival Rate
dc.subjectRisk Factors
dc.subjectRetrospective Studies
dc.subjectFollow-Up Studies
dc.subjectProspective Studies
dc.subjectAged
dc.subjectMiddle Aged
dc.subjectCaribbean Region
dc.subjectMale
dc.subjectWatchful Waiting
dc.subjectHospitals, High-Volume
dc.subjectUnited Kingdom
dc.subjectEthnicity
dc.subjectWhite People
dc.subjectBlack People
dc.titlePresentation, follow-up, and outcomes among African/Afro-Caribbean men on active surveillance for prostate cancer: experiences of a high-volume UK centre
dc.typeJournal article
pubs.publication-statusPublished
ror.mmsid9916487402301831

Files

Collections